These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25139544)

  • 21. Proteoglycans and injury of the central nervous system.
    Matsui F; Oohira A
    Congenit Anom (Kyoto); 2004 Dec; 44(4):181-8. PubMed ID: 15566408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases and proteoglycans in axonal regeneration.
    Pizzi MA; Crowe MJ
    Exp Neurol; 2007 Apr; 204(2):496-511. PubMed ID: 17254568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Extracellular Environment of the CNS: Influence on Plasticity, Sprouting, and Axonal Regeneration after Spinal Cord Injury.
    Quraishe S; Forbes LH; Andrews MR
    Neural Plast; 2018; 2018():2952386. PubMed ID: 29849554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 'GAG' reflex prevents repair of the damaged CNS.
    Sherman LS; Back SA
    Trends Neurosci; 2008 Jan; 31(1):44-52. PubMed ID: 18063497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of CSGalNAcT1, a key enzyme in regulation of CS synthesis, in neuronal regeneration and plasticity.
    Igarashi M; Takeuchi K; Sugiyama S
    Neurochem Int; 2018 Oct; 119():77-83. PubMed ID: 28987564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC.
    Kwok JC; Afshari F; García-Alías G; Fawcett JW
    Restor Neurol Neurosci; 2008; 26(2-3):131-45. PubMed ID: 18820407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration.
    Rolls A; Cahalon L; Bakalash S; Avidan H; Lider O; Schwartz M
    FASEB J; 2006 Mar; 20(3):547-9. PubMed ID: 16396993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global analysis of neuronal phosphoproteome regulation by chondroitin sulfate proteoglycans.
    Yu P; Pisitkun T; Wang G; Wang R; Katagiri Y; Gucek M; Knepper MA; Geller HM
    PLoS One; 2013; 8(3):e59285. PubMed ID: 23527152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury.
    Properzi F; Asher RA; Fawcett JW
    Biochem Soc Trans; 2003 Apr; 31(2):335-6. PubMed ID: 12653631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer.
    Silver DJ; Silver J
    Curr Opin Neurobiol; 2014 Aug; 27():171-8. PubMed ID: 24762654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans.
    Kawakami Y; Saito Y; Nakagawa R; Kurihara Y; Takei K
    Neurosci Lett; 2018 Sep; 683():61-68. PubMed ID: 29953923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondroitin/dermatan sulfate in the central nervous system.
    Sugahara K; Mikami T
    Curr Opin Struct Biol; 2007 Oct; 17(5):536-45. PubMed ID: 17928217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Properties of Neural Extracellular Matrix.
    Suttkus A; Morawski M; Arendt T
    Mol Neurobiol; 2016 Jan; 53(1):73-82. PubMed ID: 25404091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
    Rhodes KE; Fawcett JW
    J Anat; 2004 Jan; 204(1):33-48. PubMed ID: 14690476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "GAG-ing with the neuron": The role of glycosaminoglycan patterning in the central nervous system.
    Smith PD; Coulson-Thomas VJ; Foscarin S; Kwok JC; Fawcett JW
    Exp Neurol; 2015 Dec; 274(Pt B):100-14. PubMed ID: 26277685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurite elongation on chondroitin sulfate proteoglycans is characterized by axonal fasciculation.
    Snow DM; Smith JD; Cunningham AT; McFarlin J; Goshorn EC
    Exp Neurol; 2003 Aug; 182(2):310-21. PubMed ID: 12895442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redirection of neurite outgrowth by coupling chondroitin sulfate proteoglycans to polymer membranes.
    Man AJ; Leach JK; Bannerman P
    Ann Biomed Eng; 2014 Jun; 42(6):1271-81. PubMed ID: 24570390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury.
    Dyck S; Kataria H; Alizadeh A; Santhosh KT; Lang B; Silver J; Karimi-Abdolrezaee S
    J Neuroinflammation; 2018 Mar; 15(1):90. PubMed ID: 29558941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
    Stephenson EL; Mishra MK; Moussienko D; Laflamme N; Rivest S; Ling CC; Yong VW
    Brain; 2018 Apr; 141(4):1094-1110. PubMed ID: 29506186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.